Sneinton, United Kingdom

Andrew James McCarroll

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrew James McCarroll

Introduction

Andrew James McCarroll is a notable inventor based in Sneinton, GB. He has made significant contributions to the field of therapeutic compounds, particularly through his innovative patent. His work focuses on developing compounds that have the potential to treat proliferative disorders, including cancer.

Latest Patents

McCarroll holds a patent for "3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5-tetrazine-8-carboxylic acid amides and their use." This invention pertains to certain 3TM compounds, which are designed to inhibit cell proliferation. The patent also covers pharmaceutical compositions that include these compounds, highlighting their application in both in vitro and in vivo settings.

Career Highlights

Throughout his career, McCarroll has been associated with Pharminox Limited, where he has been able to apply his expertise in therapeutic compounds. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of treatments for serious health conditions.

Collaborations

McCarroll has collaborated with notable colleagues, including Malcolm Francis Graham Stevens and David Cousin. These partnerships have likely enhanced the research and development of innovative therapeutic solutions.

Conclusion

Andrew James McCarroll's contributions to the field of therapeutic compounds through his patent demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the treatment of proliferative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…